U.S. Markets open in 4 hrs 2 mins
  • S&P Futures

    4,310.50
    -7.25 (-0.17%)
     
  • Dow Futures

    33,936.00
    -107.00 (-0.31%)
     
  • Nasdaq Futures

    14,030.50
    +43.75 (+0.31%)
     
  • Russell 2000 Futures

    1,909.30
    -19.00 (-0.99%)
     
  • Crude Oil

    87.18
    +0.57 (+0.66%)
     
  • Gold

    1,791.10
    -3.90 (-0.22%)
     
  • Silver

    22.53
    -0.14 (-0.62%)
     
  • EUR/USD

    1.1135
    -0.0012 (-0.1114%)
     
  • 10-Yr Bond

    1.8070
    0.0000 (0.00%)
     
  • Vix

    30.80
    -1.16 (-3.63%)
     
  • GBP/USD

    1.3383
    +0.0002 (+0.0161%)
     
  • USD/JPY

    115.6400
    +0.3380 (+0.2931%)
     
  • BTC-USD

    36,611.84
    +31.02 (+0.08%)
     
  • CMC Crypto 200

    829.99
    +10.49 (+1.28%)
     
  • FTSE 100

    7,472.15
    -82.16 (-1.09%)
     
  • Nikkei 225

    26,717.34
    +547.04 (+2.09%)
     

Why This Cannabis Operator Is Giving Off Buy Signals

·5 min read
Why This Cannabis Operator Is Giving Off Buy Signals
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • OGI

Quarterly revenue for some U.S. multistate operators (MSOs) is coming in at record levels. On the Canadian front, New Brunswick-headquartered Organigram (NASDAQ: OGI), one of the leading producers of indoor-grown cannabis and products made from it, posted double-digit revenue growth in its most recent quarter, alongside significant market share gains this year -- yet its shares have steadily sunk since February. According to statistics posted in Organigram's corporate update on Nov. 1, based on data from HyFire, the company has nearly doubled its market share this year as of September, going from 3.9% at the end of 2020 to 7.7%.